Literature DB >> 22689809

Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty.

Nancy N Baxter1, Joan L Warren, Michael J Barrett, Therese A Stukel, V Paul Doria-Rose.   

Abstract

PURPOSE: We designed this study to evaluate the association of colonoscopy with colorectal cancer (CRC) death in the United States by site of CRC and endoscopist specialty.
METHODS: We designed a case-control study using Surveillance, Epidemiology, and End Results (SEER)-Medicare data. We identified patients (cases) diagnosed with CRC age 70 to 89 years from January 1998 through December 2002 who died as a result of CRC by 2007. We selected three matched controls without cancer for each case. Controls were assigned a referent date (date of diagnosis of the case). Colonoscopy performed from January 1991 through 6 months before the diagnosis/referent date was our primary exposure. We compared exposure to colonoscopy in cases and controls by using conditional logistic regression controlling for covariates, stratified by site of CRC. We determined endoscopist specialty by linkage to the American Medical Association (AMA) Masterfile. We assessed whether the association between colonoscopy and CRC death varied with endoscopist specialty.
RESULTS: We identified 9,458 cases (3,963 proximal [41.9%], 4,685 distal [49.5%], and 810 unknown site [8.6%]) and 27,641 controls. In all, 11.3% of cases and 23.7% of controls underwent colonoscopy more than 6 months before diagnosis. Compared with controls, cases were less likely to have undergone colonoscopy (odds ratio [OR], 0.40; 95% CI, 0.37 to 0.43); the association was stronger for distal (OR, 0.24; 95% CI, 0.21 to 0.27) than proximal (OR, 0.58; 95% CI, 0.53 to 0.64) CRC. The strength of the association varied with endoscopist specialty.
CONCLUSION: Colonoscopy is associated with a reduced risk of death from CRC, with the association considerably and consistently stronger for distal versus proximal CRC. The overall association was strongest if colonoscopy was performed by a gastroenterologist.

Entities:  

Mesh:

Year:  2012        PMID: 22689809      PMCID: PMC3413278          DOI: 10.1200/JCO.2011.40.4772

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  33 in total

1.  Colonoscopy vs sigmoidoscopy screening: getting it right.

Authors:  Alfred I Neugut; Benjamin Lebwohl
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

2.  Protection from colorectal cancer after colonoscopy: a population-based, case-control study.

Authors:  Hermann Brenner; Jenny Chang-Claude; Christoph M Seiler; Alexander Rickert; Michael Hoffmeister
Journal:  Ann Intern Med       Date:  2011-01-04       Impact factor: 25.391

3.  Prevalence of nonpolypoid colorectal neoplasia: an Italian multicenter observational study.

Authors:  M A Bianco; L Cipolletta; G Rotondano; F Buffoli; G Gizzi; F Tessari
Journal:  Endoscopy       Date:  2010-03-16       Impact factor: 10.093

4.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

5.  Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.

Authors:  Sun Hee Rim; Laura Seeff; Faruque Ahmed; Jessica B King; Steven S Coughlin
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

6.  Association of colonoscopy and death from colorectal cancer.

Authors:  Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

7.  Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.

Authors:  Hermann Brenner; Ulrike Haug; Volker Arndt; Christa Stegmaier; Lutz Altenhofen; Michael Hoffmeister
Journal:  Gastroenterology       Date:  2009-11-10       Impact factor: 22.682

8.  Effect of screening colonoscopy on colorectal cancer incidence and mortality.

Authors:  Charles J Kahi; Thomas F Imperiale; Beth E Juliar; Douglas K Rex
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-11       Impact factor: 11.382

9.  A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.

Authors:  Carrie N Klabunde; Julie M Legler; Joan L Warren; Laura-Mae Baldwin; Deborah Schrag
Journal:  Ann Epidemiol       Date:  2007-05-25       Impact factor: 3.797

10.  Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

Authors:  Nereo Segnan; Paola Armaroli; Luigina Bonelli; Mauro Risio; Stefania Sciallero; Marco Zappa; Bruno Andreoni; Arrigo Arrigoni; Luigi Bisanti; Claudia Casella; Cristiano Crosta; Fabio Falcini; Franco Ferrero; Adriano Giacomin; Orietta Giuliani; Alessandra Santarelli; Carmen Beatriz Visioli; Roberto Zanetti; Wendy S Atkin; Carlo Senore
Journal:  J Natl Cancer Inst       Date:  2011-08-18       Impact factor: 13.506

View more
  121 in total

1.  Endoscopy services and training: a national survey of general surgeons.

Authors:  Daniel Skubleny; Noah Switzer; Shahzeer Karmali; Christopher de Gara
Journal:  Can J Surg       Date:  2015-10       Impact factor: 2.089

2.  Regional variation in the use of surgery in Ontario.

Authors:  Adina E Feinberg; Joan Porter; Refik Saskin; Jagadish Rangrej; David R Urbach
Journal:  CMAJ Open       Date:  2015-07-17

3.  How I Approach Retroflexion and Prevention of Right-Sided Colon Cancer Following Colonoscopy.

Authors:  Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

4.  Colonoscopy Screening among Native Hawaiians at Queen's Medical Center between August 2011 and January 2013.

Authors:  Jodie M Kaalekahi; Krupa R Gandhi; John J Chen; Scott K Kuwada
Journal:  Hawaii J Med Public Health       Date:  2016-01

5.  Physician characteristics associated with higher adenoma detection rate.

Authors:  Ateev Mehrotra; Michele Morris; Rebecca A Gourevitch; David S Carrell; Daniel A Leffler; Sherri Rose; Julia B Greer; Seth D Crockett; Andrew Baer; Robert E Schoen
Journal:  Gastrointest Endosc       Date:  2017-09-01       Impact factor: 9.427

Review 6.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

Review 7.  Colorectal cancer screening quality, cost and practice in an era of healthcare transformation.

Authors:  Martin Brotman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

8.  Endoscopic Management of Large (≥2 cm) Non-pedunculated Colorectal Polyps: Impact of Polyp Morphology on Outcomes.

Authors:  Seon Hee Lim; John M Levenick; Abraham Mathew; Matthew T Moyer; Charles E Dye; Thomas J McGarrity
Journal:  Dig Dis Sci       Date:  2016-10-01       Impact factor: 3.199

9.  Quality indicators for colorectal cancer screening for colonoscopy.

Authors:  Philip S Schoenfeld; Jonathan Cohen
Journal:  Tech Gastrointest Endosc       Date:  2013-04

10.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Authors:  Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.